OSE Immunotherapeutics SA Sustainability Reports

OSE Immunotherapeutics is a biotechnology company focused on developing first-in-class therapies in immuno-oncology and immuno-inflammation.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

LEI: 969500HIUWVGY6NZSM05

FIGI: BBG008891XG3

14 reports from 2019 to 2025

• OSE Immunotherapeutics SA 2025 Universal Registration Document
• OSE Immunotherapeutics SA 2025 Universal Registration Document Including the Annual Financial Report
• OSE Immunotherapeutics SA 2024 Universal Registration Document Including Annual Financial Report
• OSE Immunotherapeutics SA 2023 Universal Registration Document Including Annual Financial Report
• OSE Immunotherapeutics SA 2023 Professional Equality Index